454.comContact us
About company
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, develops and commercializes novel instrumentation for high-throughput DNA sequencing. Specific applications include whole-genome sequencing, RNA analysis and ultra-deep sequencing of target genes.
US 1 commercial street
Unknown
Unknown
Not verified company
